Charlty Reslstratlon Na. 115m9 Hisnocyrosis UK KNOWN A5 HISTIO UK ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR ThE YEAR ENDED 31 MARCH 2024
HISTiocYfosis UK Hisfio UK LEGAL AND ADMINISTRAnvE INFORMATION Truste41 MrA Kontoyannls, Chalr Prof. P Beverlev Drv Nandurl Mr P Blenenstock Prof. M Collln Prnf. C 800th Dr R Tattersall Othff oft•rs Lynn Jackson, Exrcutlve Dlrector Ch•rfty numb•r 1158789 Prfndpal addrnm PO Box 159 Llsknard Cornwall PL14 9DQ Indwnd•nt •Mmln•r TC Group 33 805ton Road Holbeach Spaldlng Llncolnshlre PE12 7LR BAnk• CAF Bank Llmtted 25 KlnB5 Hlll Avenue Kln8s Hlll West Mallln8 Kent ME19 4JQ
HisllocYT051S UK HISTIO UK Trustees, report Statement of trustees, responslblllttes Independent examlner's report Statement of flnanclal acrfvftles Bilance Sheet 10 Notes to the flnanclal statements 11.18
HISTiocYfosis UK Hisllo UK TrUSTEES' REPORT FOR ThE YEAR ENDED 31 MARCH 2024 The trustees present thelr report and flnanclal statements for the year ended 31 March 20 ObJe¢tlveJ and actlvltlei Publk benefft The object of the CIO Is the rellef of slckne55 Jnd preservatlon of good health arnon8 patferts affected by hlstloLVtlc dlseases thelr famllles and carers, In partlcular but not exclu51vely ty: (l) the promotlon and furtherance of sclentlflc research Into the physloloBy and patholo8y of hIOLytes and the aetlolo8y of hlstlocytocytlc dlseases, the useful results of whlch wlll be dlssemlnated for the publk benefft; (11) the development of more accurate means of dlagnosls, Improved protocols for mana8ement of patlents and uhlmately measures for preventlon of hlstlocytlc dlseases. (111) the provlslon and dlssemlnatlon of Inforni•tfon, educatlon and kn(wledse In 5UPPQrt of ydents Ind famllles affected by the dlsease to Include the medlcal professlons and 8eneral publlc: (Iv) collaboratlon wlth Interested Indfvlduals and or8anlsatlons. The Trustees conflrm that they have referred to the 8uldance contalned In the Charlty Comrnlsslon's 8eneral guklance on publ1¢ benefft when revlewln8 the Charttls alms and objecdves and In plannlng future actlvltles and settln8 the grant makln8 pollcy for the year. The Charlty carrles out these objectlves by focusln8 on these areas through whlch we achleve our strate8lc prlorltles of malntalnlng a stsble pro8rnmme and the contlnued fundln8 of vltal research. The beneffts of the CharftS work are the development of future research, the dIsmInatIon of research Ilndln8S, the development of new theraples and the fundln8 of on-golng research wlth the 8oal belng able to Infomi sufferers, thelr carers and famllles. The trustees confirni that they ha complled wlth the requlrements of section 17 of the CharltlesAct 2011 to have due regard to the publlc benefft 8uld8nce publlshed by the Charlty Commtsslon for England and Wales. Flnandil Report Investmentpollry and oblectlves The CharltVs pollcy at present Is to Invest In Iow-rlsk and reasonably Ilquld assets, so that funds are avallable to meet any unforeseen needs that may arlse. for exarnple, as a consequence of meetlng actlvltles. As far as posslble, the Charlty seeks to follow an ethkal Investment strJte8Y that precludes Inv&ttn8 In any company whose activltle5 may ha an adverse lrnpart on the underlyln8 beneficlarle5 of the charlty. Whlle strlvlng for the hlghest ethlcal stsndards. the Charlty wlll adhere to the Charlty Commlsslon's rule that we maxlmlse the Income of the charlty wlthout exposure to undue rtsk.
Hisnocyrosis UK HISTIO UK TrUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MAR012024 Flnandal revlew The Chalrrnan re8ul8rly revlews the reserves of the charlty to ensure that sufflclent Ilquld funds are avallable to the Charlty to meet Its on8oln8 obllEatlon$. The reserves throu8hout the accountln8 perlod have been adequate to fujftl thls objectlve. Inmme a Expendfture Summary The 2023-2024 Income was Steady agalnst the prevlous flnanclal yejr. Charltle5 In general sufferln8 from the contlnued downturn In the cost of Ilvlng raTsln8 concerns In the 'cost of 81vIn In thls econornlc dlmth. We thank all of our generous donor5, the Indlvlduals, cornmurllty 8roups, schools, corporate supporters. Charltles and Foundatlons that contlnued thelr support and refiect5 the excellent partlclpatlon, drhe and 8enerosOty of our communtty fundralser5, SUPPOrters, famllles and committed Indlvlduals that have bfftn able to asslst us malntaln the Charlty. 6rnntAwar In 2023 Hlstlo UK placed a call for Researth Paper5, eleven appllcatlons were recelved. After sub5tantlal revlew by the Sclentlflc Revlew Board and conflrmatlon of the Board of Trustees In February 2024 an award dfer was mode to: Tatlana von Bahr Greenwood,. MD, PhD and her tsam for a project to Establlsh a European CNSLCH Ré8lstry In the sum of £50,CIJO made In February 2024. Gronts Recelved Nll In the flnanGl•l year Chalrmin'i St•t•M•nt Flnonclal Thls year contlnues to place a strnln on our Charlty Income, In118ht of thls we have adjusted ourpractlses and bud8ets. Refiectlng on thls past year of operatlon we are 8rateful for the amazlng support that we have recelved, both In funds and the tlme and energy of our amazln8 volunteers and Hlstlo Champlons. We contlnue to recognlse that the current economk dlmate effects not only us, but all of our Hlstlo Communlty and beyond remalnln8 a very dlfflcult perlod for all. De5pFte reduced Income we have been able to contlnue our Inforniatlon Support servkes and Partnershlp Project5. We are very pleased to have contlnued and further developed our varlous Hlsttocytlc Informatlon 8uldes and soclil medla plattorms allowln8 US to engage further wlth our Patlents, Parents and Supporter5. In assoclat5on wlth our partners, we wlll contlnue to support hlstlocytlc profe551onals, patlents and famllle5 wlth up-ttrdate Informatfon on these devastatln8 dlsorders as It becomes avallable. Thankyou all.
HisfiocYTOSIS UK HISTIO UK TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024 Partn•rshlps H141AfG Haemophagocyrfc Lynyhohlsrfocytwb IHUIJAcross Spedallty Collaboradon Hlstlo UK provldes webslte admlnlstratlve support to th15 amazln8 8roup. Hlstlo UK provldes webslte admlnlstratlon to thls establlshed r4lstry program. PPPIE Panel-Paden¢ Paren¢ Publk Inement a Enqaoement Panel Hlstlocytosls UK Is commltted to me•nln8ful patlent and publlc Involvement and publlc en8a8ement fi)r and on behalf of not onty tts own Grant Fund Awards but to apprn15e those of other Researchers and or Orgartsatlons In the fleld af research wlth prlorlty to those of Hlstfocytlc dlseases. Our vhlon wlth M8ards to patlenL parent and publlc Involvement and en8a8ement Is- "to establlsh a culture wTrthln Hlstlocyt0515 UK where our communlty has the skllls and resources t opJmlse and dellver patlent and publlc Involvement and en8a8ement and It15 Inte8rated In to our ways of worklng and throughout the research we fund and appralse. Hlstlocytosls UK his, In consultatlon wlth researcher6, publlc contrlbutors and Invofvement professlonals, Identffied 6 Jlm5 that wlll 8ulde Hlstlocytosls UK and Its en8a8ement programme to work towards It's vlslon that No one should dle of H15tlocytOs1s: Ensure our research communlty Incorporates patfent and publlc Involvernent and engagement throughout research. Incorporate relevant Involvement throu8hout our fundlré processes. Lead by example In our Involvement and enp8ernent practlce. Strengthen Involvement and engagement practlce of Hlstlo UK'S PJtlenL Parent & Publlc Involvement Enga8ement Panel. Insplre and encournge Incluslve, Innovatlve, dlver5e and creatfve patlent, parent and publlc Involvement and engagement. Improve the knowled8e 5harln8 of patlent, parent and publlc Involvement and ew8ement. The Hlstlocyt• Socl•ty The HS Is the or8anlsatlon representln8 cllnlcal and research profe551onals In the field of Hlstlocyttc dlsorders. They have agreed to share thelr vlrtual educatlonal programme wlth us durlng the 2023-2024 perlod. The Nlkol•J Symposlum Offerln8 the opportunlty to showcase new Ideas, facllltate asplratlonal thlnklng, and develop InnatIve research.
Hisriocyrosis UK Hisfio UK TrU5fEE5' REPORT (CONTINUED) FOR THE YEAR EPIDED31 MAR012024 Awar•n•ss Hlrtlocytosli UK 2024- Vlrtwl F(Yum on 18th January Bulldlng on prevlous years, the fomiat of the 2024 programme for the Vlrtu81 Forum Included the ddlvery of Abstracts, enabllng a platform for not only establlshed spedallsts but Introduced emer8ln8 new talent In the fleld of H15ttocytlc dISorde to a speclallsts audlence from the UK ind around the world. HLH & Hyp•rlnfl•mm•tory Jyndrom•. Hojtr. Dr RIdl T•tternill AbrtrKt Pr•Mnt•rn A B Verbeek Elena Slenel Danlel Gtro Speakern Dr. Blt• Sh•koory - Translatlonal Autolnfiammatory Dlseases Sect10 Natlonal Instltutes of Health Bethesda, Maryland. US A Mult1411s¢lplln•ry Approach to [DIa8nli ind Manapm•ntJ of E•rty/suJpert•d H•MoPh•¢Ytlc Lwnphohlst1owJlM•¢r0Ph•• Acdvatlon Syndrom• Dr. JeMlc• Mann - Consultant Rheumjtologht at UCLH, and Assoclate Honorary Professor at UCL A practlral approach to th• m•na8•m•rt of p•tlents vAth HLH In th• UK L•ns•th•M Cell Hljtlocytosls & other r•rnr dIrder5- Hojt Prof. Matthew Collln Dr. C•rl Allen - Mllton and Allene Nlrken Ch•lr In Paedlatrfc Oncologyi Texa$ Chlldren's Hospltal Co-Dlrector, HIS0CytoS75 Pro8ram Co-Dlrertor, Lyrnphoma Pro8rarn Dlrector of Research, Global Haematol08OnCol06Y edIatrIC Excellence IHOPEI Professor, Department of Paedlatrlcs, Sectlon of HaematologwOncolo8y, Baylor Colle8e of Medlclne. LCH2024: Pro8r•ii, Chaw •nd Opportunltl•J7 Plans for the futurn Hlstlo UK remalns at the forefront In challenglng these dev4statln8 dlsorder5, we wlll contlnue b IlId on the transfer of Infomiatlon and knowledge avallable natlonalty and Internatlonal throu8h our commlttee Structure to parents, paiients and medlcal professlonals.
HISTIOCYTOSIS UK HISTIO UK TRusfEES' REpoirr ICOhmNUEDI THE YEAR ENDED 31 MARCH 2024 stctur pv•rn•nce •nd rn•na8•m•nt gonlsaiionalstructure Hlstlocytosls UK Is a rewstered charlty. nurnber 1158789, and Is constltuted as a charltable Incorporated or8an15atlon In En8lind and Wales. The Charlty actlvely fundralses and seeks to )nIlTrUe the charltable work deslred by the donor thUgh the careful stewardshlp of its exlstln8 resources. At the annual Trustees, meetlngs, the Trurtees agree the broad strats8y and areas of actlvlty for the Charlty, Includln8 conslderatton of 8rant makln& InvestmenL reseNes and rf5k management pollcles ind performance. The day4Trday admlnlstrntlon of 8rants and the processln8 and handlln8 of appllc•tlons prfor to conslderatlon by the Charfty Is dele8ated to the Executfve Dlrector. The Charlty's Independent Sclentlflc Revlew Board conslder 811 applkatlons agalnst a8reed crlterkn prlor to makln8 recommendatlon to the Charlty on fundlng grants. The SRB revlew all appllcatlons recelved In response to calls for proposals. Th• Chalr of t1 5RB lor 202>2024 Professor Peter Beverley MBBS, DS4 Fmedscl Vlc•<halr Professor Matthew Collln. BM, Bch, Dphll. MRCP, FRCPath The Trustees mlew on a re8ular basls both to recrult new Trustee{s) for thelr experfence, empathy and knowledge of the charlty and to keep the skllls and composftion of the Trustee body and 5ucce551on plannln8 under revlew. Move Into our new flnanclal year Trustees wlll retire at the end of thelr term of offlce wlth the Charlty. As Iwaysi we wlll tak thts opportunlty to revlew our Governance structure and assess the benefits of utlllsln8 any opportunltles that may be derlved from advtsory boards allowln8 U5 to more fulty sUPPOrt the Execut Dlrector In forthcomlng projects and Inltlatfves and at the same tlme focus on our stren8th$. Fundrqblnq Requlaiion The Charlty Is re8lstered wlth the Fundratslng Re8ulator and Is In full compllance wlth Its requl*ments. The Charlty adheres to the key prlnclple5 and behavlour5 In that the work of its fundrn151n8 wlll be Le8al. Open, Honest and Respectful. Rlsk manaqement The Trustees have considered the major rlsks to whlch the charlty Is exposed and have revlewed those rfsks and estsbllshed systems and procedures to manage those rf5ks. The Trustees conslder varlablllty of Inve¥(ment returns.
Tro clo to ••rvA Its ty •1 •Jr fjr th•lr ladmkyl Irawn I¢ •ppmdb¥th••o•nlrfTnM •ArA Kon
Hisnocyrosis UK Hisno UK srArEMEhrr OF TrusfEES' RESPONSIBIUTIES FOR ThE YEAR ENDED 31 MARCH2024 The trustees ore responslble for preparln8 the Trustees, Report and the flnandal ststement$ In accordance wlth appllcable law and Unlted Kln8dom Accountln8 Standard5 {Unlted Kln8dom Generally Accepted Accountln8 Practlce). The law appllcable to charltles In England and Wales requlres the trustee5 to prepare financlal ststements for each financlal year whlch Slve a true and falr vlew of the state of affalrs of the charlty and of the Incomlng resource5 and appllcatlon of resources of the charlty for thit year. In preparln& these flnandal statements, the trustees are requlred to: - select suftable accountln8 pollcles and then apply them conslstentlyl - observe the methods and prlndples In the Charltles SORP; - mjke Jud8ements and estlmates that are reasonable and pNdent: - stste whether appllcable accountfrq standards have been followed, subject to any materlal departures dlsclosed and explalned In the flnjnclal 5titement5' and prepare the Iln•nclal ststements on the 8oln8 concern basls unless It Is Inapproprlate to presume that the thjrfty wlll contlnue In operatlon. The trustees are responslble for keeplna sufflclent accountlng records that dlsclose wlth reasonable accuracy at anytlme the flnancljl posltlon of the chorlty and enable them to ensure that the flnanclal statements comptywfth the Charltles Act 2011, the Charlty (Accounts and Reports) Re8ulatlons 2(X)8 and the provlslons of the trust deed. They are •150 responslble lor safe8u•rdln8 the assets of the charlty and hence for takln8 reasonable Steps for the prevendon and detectlon of fraud and other Irregularltles.
Hisriocyrosis UK HISTIO UK INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF Hisnocyrosis UK I report to the trustees on my examlnallon of the flnanclal statements of Hlstlocytosls UK tthe charlty) for the year ended 31 Marth 2024. R•8ponslbllltlqi •nd b•Jls ol report As the trustee5 of the charlty you are responslble for the preparntlon of the flnanclal statements In accordance wtth the requlrements of the Charttles Act 2011 (the 2011 Act). I report In respect of my examlnatlon of the charlty s flnanclal statsrnents carrled out under 5ectlon 145 of the 2011 Act. In carryln8 Out my examlnatlon I have followed all the appllcable Dlrectlons glven by the Charlty Commlsslon under sectlon 145(5)(b) of the 2011 Art. Ind•p•nd•nt •xomlner* thtem•nt Your attentlon Is drawn to the fact that the charlty has prepared flnanclal statsments In accordart• wfth Accountln8 and Reportfn8 by Charftles preparln8 thelr accounts In accordance wlth the Flnandjl Rep(Ttln8 Standard appllcable In the UK and Republlc of Ireland IFRS 102) In preference to the Accountlng and Reportlng by Charltles: Ststement of Recommended Practlce Issued on l Aprll 2005 whlch Ls referred to In the extant re8ulatlons but has now been wlthdrawn. l understsnd th•t thls has been done In order for fln•nclal statements to provlde a tru4 and falr vhw In accordance wlth Generalty Accepted Accountln8 Pracilce effectlve for reportln8 perfods be8lnnln8 on or after l Jinuary 2015. I have completed my examlnatlon. I confirm that no matters have come to my attentlon In connectlon wtth the ex?mlnatlon 8lvln8 me cause to belleve that In any materlal respect: accountln8 records were not kept In respert of the Charfty w requlred by sectlon 130 of the 2011Act; or the flnanclal statements do not accord wlth those records: or the financlil statements do not comply wlth the appllcable requlrements concernlng the fomi and content of accounts set out In the Charltles (Accounts and Report51 Regulatlons 2008 other than any requlrement that the accounts 8fve a true and falr vlew whlch Is not a matter consldered as part of an Independent examlnatlon. I have no concerns and have come Jcross no other matters In connectfon wlth the exarnlnatlon to whth attentlon should be drawn In thls rnport In order to enable a proper understsndln8 of the financlal statements to be reached. Chrlstopher McKenna ACA TC Group 33 Bostan Road Holbeach Spaklln8 Lincolnshire PE12 7LR Datsd: .l.llk21.44.......
HISTiocYfosis UK Hisllo UK srATEMEhrr OF FINANCIAL p£nviTIES INCWDING INCOME AND OtPENDrruRE ACCOUNT FOR THE YEAR ENDED 31 MARCH2024 Unrertrkted Unrestrkted Restrlcted fundl funds funds 2024 2023 2023 Totsl 2023 Donatlons and le8acles Investments 121,963 4,864 141,526 1,704 9,0 151,426 L704 Tot•1 Incom• 126,827 143,230 9,9C 153,130 Ralslngfunds 1,281 1,073 1,073 Charltablè athttles 138,011 153,783 9,900 163,683 Totsl r•Tea1 •xp•nded 139,292 154,856 9,9C 164,756 N•t exp•ndltur• for th• y•ar/ N•t mov4m•nt In fun (12,4651 (IL6261 IIL626) Fund balances at l Aprll 2023 416,177 427,803 427,803 Fund hl•nceJ •t 31 March 2024 403,712 416,177 416,177 The statement of flnanclJl actlvftles Includes all 8alns and10sses recogntsed In the year. All Income and expendlture derlve from contlnuln8 actMtle5.
HMI£> L AfATJI AIAAa12024 at nk irnl In nd 417306 on• 1425Jj 414111J 4*177 401712 177 &177 nts wwe lpprnd bythi Ihtyw on. MrAKf •nnl4 Chr 10-
HISTiocYfosis UK Hisfio UK NOTES TO THE FINANCIAL STATEMENIS FOR THE YEAR ENIXD JI MARai 2024 Account1 pollclqs 1.1 Accountln8 nntIon The flnanclal statements have been prepared In accordance wlth the charlty's 8overnlng document, the Charltles Act 2011 and "Accountln8 and Reportln8 by Charltles: Statement of Recommended Practlce appllcable to charltle5 preparlng thelr accounts In accordonce wlth the Flnanclal Reportln8 Stsndard appllcable In the UK and Rewblk of Ireland (FRS 102) (effectlve l January 2019)" The charlty Is a Publlc Benefit Errtlty as defined by FR5 102. The charlty ha5 tsken advantage of the provlslon$ In the SORP for charttles applyln8 FRS 102 Update Bulletln I not to prepare a Staternent of Cash Flow5. The flnanclal statements have departed frorn the Charltle5 (Accounts and Reports) Re8ulatlons 218 onty to the extent requlred to provlde a true and falr vlew. Thls departure has Involved followln8 the StJtement of Recommended Practlce for charftles applyln8 FRS 102 rnther than the verslon of the Ststement ol Recommended Practlce whlch Is referred to In the Re8ulatlons but whkh has slnce been wlthdrawn. The flnanclal ststements Jre prepared In sterlln8, whlch Is the functlonal currency of the charfty. Monetsry •mounts In these flnandal statsments are rounded to the nearest £. Thé financlll statsments have been prepared under the hlstorlcil cost conventlon, modlfled to Include the revaluatlon of freehold propertles and to Indude Investment propertles and rtaIn flnanclal InY<ruments at falr value. The prlnclpal accountln8 polkles adopted •re set out below. L2 6olryT conc4rn At the tlme of approvlnB the flnanclal statements, the trustees hm a reasonable expectatlon that the charlty has adequate resources to contlnue In aperatlonal exlstence for the foreseeable future. Thus the trustees contfnue to adopt the 8oln8 concern basts of accountln8 In preparfn8 the flnanclal stotsments. 13 Ch•ritsble funds Unrestrfcted funds are avallable for use at the dISctiOn of the trustees In furtherance of thelr charltsble obJeLtlves. Restrlrted funds are subject to speclflc condltlons by donors as to how they rnay be used. The purFThes and uses of the restrlcted funds are set out In the notes to the flnanclal stementS. Endowment fvnd5 are subject to speclflc condltlons by donors that the capftal must be malntsined ty the charlty. Income Is recognlsed when the charlty Is le8alty entltled to It after ary performance condlllons hwe been m¢ the amounts can be measured rellably, and It Is probable that Income wlll be recAfved. Cash donatlons are recognlsed on recelpt. Other donatlons are recognlsed once the chartty has been notified of the donation, unless performance conditions requlre deferral of the amount. Incorne tax recoverdble In relatSon to donations received under Gfft Ald or deeds of covenant Is recognised *( the time of the donatlon. 11
HISTiocYfosis UK HISTIO UK NOTES TO THE FINANCIAL STATEMENTS {coNllNUED) FOR THE YEAR ENDED 31 MARCH2024 Account1 polldej (Contlnuqd) Le8acles are reco8nlsed on recelpt or otherwlse If the charlty has been noffied of an Impendlng dlstrlbutlon, the amountls known. and recelpt Is expected, If the amount Is not known, the legary b treated 45 a contln8ent asset. LS Exp¢ndltur• All expendfture Is recogntsed once there Is a legal or constructlve obll8atlon to that expendltur4 tt 15 probable settlement ts requlred and the amount can be measured rellabty. All costs are allocated to the appllcJble expendlture headln8 that 088re8ate slmllar costs to that category. Where costs cannot be dlrectlv attrlbuted to partlcular headln85 they have been allocated on • basls conslstent wlth the use of resources. wlth central staff costs allocated on the bas15 of tlme spen¢ and depreclatlon charges allocated on the portlon of the asset's use. Other 5UPPOrt costs are allocated based on the Spread of staff costs. Ralslnifvnds These are costs Incurred In attrnrtln8 voluntsry Income, the mana8ement of Investments and those hcurred In trndln8 aCtlvltle5 that ralse funds. Chorltable actfvl Charftable expendfture comprtse5 those costs Incurred by the charlty In the dellvery of It5 acuvttes and servlces for Its beneflclarles. It Includes both costs that can be allocated dlrectly to suth actlvltles ind those Costs of an Indlrect nature necessary to support them. 1.6 Tan8lble fixed Trn8lble flxed assets are Inlllpjlty measured at cost and subsequently measured at cost or ValtIOn, net of depredatFon and any Impalrnient losses. Depreclatlon Is reco8nlsed so as to wrfte off the cort or valuatlon of assets less thelr resldual values ¢)ver thelr useful Ilves on the followln8 bases: Office equlpment 33% reducln8 balanc• The galn or loss arfslng on the dlsposal of an asset Is deternilned as the djfference between the sale proceeds and the carryln8 value of the asset, and15 rew8nlsed In net Incomel(expendlture} forthe year. 1.7 Impalrmqnt offd asmts At each reportln8 end date, the charlty revlews the carryln8 amounts of Its tan8lble assets to determlne whether there 15 any Indlcallon that those assets have suffered an 1mpalrrnerrt1055. If any such Indlcatlon exlsts, the recoverable amount of the asset Is estlmated In order to deternilne the extent of the Implrment lou lff any). Cmh Jnd cuh qqulv41ents Cash and cash equivalent5 Include 5h In hand, deposlts held at call wlth banks, other shorkterm Ilquld In4r5tment5 wtth 0rf8lnal maturftles of three rnonths or le55, and bank overdrnfts. Bank overdrafts are shown wtthln bom)wlngs In Crrent Ilabllltle5. 12-
HISTiocYfosis UK Hisfio UK NOTES TO THE FINANaAL STATEMENTS ICONTINUED) FOR THE YEAR ENDE031 MARCH 2024 Accountlnl polld (ContInu} 1.9 Fln•ncl•l Instrum•nts The charlty ha5 elected to appty the provlslons of Sertlon 11 '8Jslc Flnancljl Instrument5, and Sectlon 12 'Other Flnanclal Instruments Issues. of FRS 102 to all of tts flnanclal In¥(ruments. Flnanclal Instruments are recogntsed In the charlty's balance she¥( when the charlty becomes party to the contrartual provlsk>ns of the Instrument. Flnanclal assets and Ilabllltles ire offset, wlth the net amounts presented In the flnanclal stjtsrnents, when there Is a le8alty enforceable rlght to set off the recognlsed amounts and there b an Intentlon to Settle on net basls or to reallse the asset and settle the Ilablllty slrnultsneouslv. 8aslcflnandal assets Baslc financlil J55ets, whlch Include debtors and cash and bank balano$. are Inltl•lly measured trnnsactlon prfce Indudlng transactlon costs and are subsequently carrfed at •mort15ed cost U51n8 the effectlve Interest method unless the arrangement constftutes a financln8 transacllon. where the trarsactfon Is measured at the present value of the future recelpts dlscounted at a market rate of Interest. Flrnndal ai$•t$ classffled D5 Mcelvable wfthln one year are not amortl$ed. 8aslcflnonclolllobllllles 8•slc flnanclal Ilibllltfes, Indudlng credltors and bank loans are Inltlally reco8nlsed ot trnnsactlon prfce uftless the arrangement constltutes a flnanclnB trnnsactlon, where the debt Instrument Is measured atthe present value of the future payments dlscountsd at a rnarket rate of Intsre5t. Flnan¢lal Ilabllltfe5 cla55Med as payable wlthln one year are not amortlsed. Debt Instruments are subsequently carrled at amortlsed cost, U51n8 the effectlve Interest rate method. Trade credltors are obll8atlons to pay for goods or servlces that have been acqulred In the ordlnary course of operjtlons from suppllers. Amounts payable are classffied as current Ilabllltles Ir payment Is due wfthln one year or less. If no( they are presented as non-current Ilabllltles. Trade credltors are recognlsed Inltlally at transactlon prke and 5ub5equently measured at amortlsed cost usln8 the effectlve Interest method. Derecognftlon offlnanclalllabllldes Flnanclal Iljbllltles are derecognlsed when the charws contrattual obll8atlons explre or are dlscharyd or cancelled. LIO Employ•• b•n•fits The cost of any unused hollday entltlement Is reco8nlsed In the perlod In whlch the employee'5 servlces are recefved. Termlnatlon benefits are reco8nlsed Immedlately as an expense when the charY 15 demorlstrably commltted to termlnate the employment of an employee or to provlde termlnatlon beneflts. 13-
HISTIOCYTOSIS UK HISTIO UK NOTES TO THE FINANCIAL sfAIEMENIS (coNllNUEDI FOR THE YEAR EIVDED 31 MARCH 2024 Crltlcal account1 rftlm•tes and Ju*m•ri In the appllcatlon of the charltvs accountln8 pollcles, the trustees are requlred to makn Judgements, estlmates and as5umptlons about the carryln8 amount of assets and Ilabllltles that are not readlty apparent from other sources. The estlmates and assoclated assumptlons are based on hlstorlcal experlence and other factors th•t Jre consldered to be relevant. Actual results may dlfferfrom these estlmates. The estlrnatss and undertylng assumptlons are mlewed on an on8oln8 basls. Revlslons to accountln8 estlrnates are recognlsed In the perfod In whlch the estlmate Is revlsed where the revtslon affects lY thot perlod, or In the perlod of the revlslon and future perlod5 where the revlslon affects both current and future perlods. Donatlons and l•8ad•i Unrnstrkted Unrestrkted Restrlcted lunds funds funds Total 2024 2023 2023 2023 Donatlons and 8lfts 121,963 141,526 151,426 Don•tlanJ and glta Donatlons Glft ald tsx reclalrned 120,569 1394 141,401 125 151,301 125 12L963 141,526 9,9C 151,426 Invertments UTrr•Jtrlrted Unre5trlrted funds funds 2024 2023 Interest recefvable 4,864 1,704 14-
HISTiocYf0515 UK HISTIO UK NOTES TO THE FINANCIAL sfATEMENTS IcoKfiNUEDI FOR THE YEAR ENDED31 MARCH2024 R•liln8 funds Unr•strfct•d Unrestrfcted funds funds 2024 2023 General fundra151n8 and event expenses 1,281 1,073 1,281 L073 Charftsble •rtlvhle8 Charftabh Charltabl• Exp•ndlture Exp•ndltur• 2024 2023 Staff costs Depreclatlon Outreach costs Travellln8 Insurance Telephone Computer expense$ Prlntln& posta8e, stallonery ind advertlsln8 Accountsncy fees Bank charges Interest payable 58.986 419 IL937 4,289 1,170 4,077 2,218 3,103 1.584 60 57,246 624 17,949 5,114 1,197 2,131 1,541 3.960 IA76 72 87,986 91,310 Grnnt fundln8 of actlvltles {see nots 7) 50,025 72.373 138,011 163.683 Anal1* by fund Unrestrlcted funds Restrlcted funds 138,011 153,783 9,9Crf) 15-
HISTIOCYTOSIS UK HISTIO UK NOTES TO THE FINANCIAL sfATEMEpifs (CONTINUEDI FOR THE YEAR ENDED31 MARCH2Q24 Grants pAyabl• Charftsbl• Charltable Exp•ndltur• Expendtture 2024 2023 Research costs 50.025 72,373 50.025 72.373 8 Truits•J None of the trustees (or any persons connected wlth them) recelved any remunerntlon or beneffts fm the charlty durln8 the year. Employ• The evera8e rnonthly number of employee5 durlng the year wi5: 2024 Numb•r 2023 Numb•r Employment costs 2024 2023 Wa8es and salarles 58,986 57,246 16-
Hisnocyrosls UK Hisno UK NOTES TO THE FINANCIAL sfATEMENTS (coNnNUED) FOR THE YEAR EAIDED 31 MARCH 2024 10 Tan8lble fthd ass•ti Ollk••qulpm• At l Aprll 2023 5A90 At31 March 2024 5,45YI D•pretl•tfon and Imp•lmi•nt At l Aprll 2023 Depreclatlon char8ed In the ye•r 4,221 419 At 31 March 2024 C•ffyln8 •mount At 31 March 2024 850 At 31 March 2023 1,269 11 D•btor4 2024 2023 Amounts falllni du• wlthln one ye•r: Prepayments and accrued Income 941 855 12 Credltsrs: amounts f•llln8 due wlthln one yr 2024 2023 Other taxatlon and soclal securlty Accru•15 and deferred Income 1,950 1,512 I13 3A62 3,253 17-
HISTiocYfosis UK Hisllo UK NOTES TO THE FINANaAL sfATEMENTS (coNnNUED) FOR THE YEAR EPIDED 32 MAR012Q24 13 Ana1$ of not amets b•tw•en lund• Unr•strict•d Unrestrlcted Restrlcted fvnds funds funds 2024 2023 2023 Totsi 2023 Fund balances Jt 31 March 2024 are represented Tarble assets Current assets1{Ilabllltlesl 850 402.862 1.269 414,908 1,269 414.908 403,712 416,177 416.177 14 R•knted prty tr•nM¢tl¢)ni Tharn were no dlsclomblo related party transactlons durln8 the •r (2023- none). 18-
Document Activity Report
Document Sent
Mon, 17 Jun 2024 08:25:00 GMT
Document Activity History
Document history shows most recent activity first
Date
Activity
You can verify that this is a genuine Portal document by uploading it to the following secure web page:
http://tcgroup2.accountantspace.co.uk/messages/VerifyDocument